Samarth Kulkarni
Chief Executive Officer at CRISPR THERAPEUTICS AG
Net worth: 28 M $ as of 30/03/2024
Profile
Samarth Kulkarni is Chairman of Casebia Therapeutics LLP. Dr. Kulkarni is also on the board of Black Diamond Therapeutics, Inc., Repare Therapeutics, Inc. and Centessa Pharmaceuticals Ltd. and Chief Executive Officer & Director at CRISPR Therapeutics AG and Director-Emerging Companies Section at Biotechnology Innovation Organization. In the past Samarth Kulkarni held the position of Partner at McKinsey & Co., Inc. He received a doctorate from the University of Washington and an undergraduate degree from Indian Institute of Technology New Delhi.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CRISPR THERAPEUTICS AG
0.48% | 14/04/2024 | 408,122 ( 0.48% ) | 28 M $ | 30/03/2024 |
| 21/06/2023 | 0 ( -.--% ) | - $ | 30/03/2024 | |
| 15/05/2023 | 0 ( -.--% ) | - $ | 30/03/2024 | |
REPARE THERAPEUTICS INC.
-.--% | 07/06/2023 | 0 ( -.--% ) | - $ | 30/03/2024 |
Samarth Kulkarni active positions
| Companies | Position | Start |
|---|---|---|
| CRISPR THERAPEUTICS AG | Chief Executive Officer | 30/11/2017 |
| REPARE THERAPEUTICS INC. | Director/Board Member | 31/10/2019 |
| BLACK DIAMOND THERAPEUTICS, INC. | Director/Board Member | 30/11/2019 |
| CENTESSA PHARMACEUTICALS PLC | Director/Board Member | 22/02/2021 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Corporate Officer/Principal | - |
CRISPR Therapeutics, Inc.
 CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of CRISPR Therapeutics AG, CRISPR Therapeutics, Inc. develops gene-based medicines for the treatment of human diseases. The private company is based in Cambridge, MA. The CEO of the company is Samarth Kulkarni. | Chief Executive Officer | - |
Former positions of Samarth Kulkarni
| Companies | Position | End |
|---|---|---|
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Corporate Officer/Principal | 30/06/2015 |
Casebia Therapeutics LLP
 Casebia Therapeutics LLP Miscellaneous Commercial ServicesCommercial Services Casebia Therapeutics LLP provides physical, chemical, and analytical testing services. The British company was founded in 2016, and Jim Burns has been the CEO of the company since 2019. | Chairman | - |
Casebia Therapeutics LLC
 Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | Director/Board Member | - |
Training of Samarth Kulkarni
| University of Washington | Doctorate Degree |
| Indian Institute of Technology New Delhi | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| BLACK DIAMOND THERAPEUTICS, INC. | Health Technology |
| CENTESSA PHARMACEUTICALS PLC | Health Technology |
| Private companies | 6 |
|---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
| Repare Therapeutics, Inc. | |
CRISPR Therapeutics, Inc.
CRISPR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of CRISPR Therapeutics AG, CRISPR Therapeutics, Inc. develops gene-based medicines for the treatment of human diseases. The private company is based in Cambridge, MA. The CEO of the company is Samarth Kulkarni. | Health Technology |
Casebia Therapeutics LLC
Casebia Therapeutics LLC Pharmaceuticals: GenericHealth Technology Casebia Therapeutics LLC is a joint venture company that focuses on discovering, developing, and commercializing gene-editing therapeutics to treat genetic causes of bleeding disorders and autoimmune diseases. The company is based in Cambridge, MA. | Health Technology |
Casebia Therapeutics LLP
Casebia Therapeutics LLP Miscellaneous Commercial ServicesCommercial Services Casebia Therapeutics LLP provides physical, chemical, and analytical testing services. The British company was founded in 2016, and Jim Burns has been the CEO of the company since 2019. | Commercial Services |
- Stock Market
- Insiders
- Samarth Kulkarni
